Arrivent Biopharma Inc (AVBP)

R&D Expense Growth

12.55%

Quarterly · Period ending:

AVBP logo

AVBP R&D Expense Growth

Latest reported12.55%
AVBP Quarterly R&D Growth (QoQ) (0.00% → 12.55%)
High-resolution chart · PNG

AVBP r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Arrivent Biopharma Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
12.5528%
16.9138%
0.0249%
16.0426%
-54.7717%
203.9677%
0.3734%
-7.7601%
28.2946%
-15.1674%
40.1261%
-29.8556%
98.8863%
18.3763%
-14.2928%
72.5058%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.